118 Early phase II study of biochemical modulation chemotherapy (BCM) using 5-fluorouracil (5-FU) and cisplatin (CDDP) for advanced non-small cell lung cancer (NSCLC)
- 1 August 1997
- journal article
- Published by Elsevier in Lung Cancer
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: